Literature DB >> 1921158

Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

A P Wieslander1, M K Nordin, P T Kjellstrand, U C Boberg.   

Abstract

Peritoneal dialysis (PD) fluids are known to suppress the reactions of inflammatory cells in vitro. PD-fluids have also been shown to have cytotoxic influence on mesothelial cells. The combinations of these factors may have a detrimental effect on the peritoneum or may impair cellular defence against bacterial peritonitis. Some authors have discussed the relevance of heat sterilization to both so-called peritoneal side-effects and to chemical decomposition of fluids. Four commercial PD-fluids and one laboratory-made PD-fluid were tested for cytotoxicity on a cultured fibroblast cell line, L-929. Cytotoxicity was determined as an inhibition of cell growth by quantification of total protein. The laboratory-made PD-fluid was sterilized either by filtration or by filtration and heat. The commercial and the heat-sterilized laboratory made PD-fluids caused significant inhibition of cell growth (53 to 76%) in contrast to saline and the filter-sterilized laboratory-made PD-fluid. Since the pH values of all the testsolutions were neutral, low pH was not the cause of toxicity. Our results regarding the L-929 cells indicate that the cytotoxicity of PD-fluids is of a general nature. Furthermore, the results indicate that the heat sterilization process might be partially responsible for causing toxicity in PD-fluids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921158     DOI: 10.1038/ki.1991.182

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer.

Authors:  Ken-ichi Kaneda; Keiichi Miyamoto; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

3.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

Review 4.  Cardiovascular risk in the peritoneal dialysis patient.

Authors:  Raymond T Krediet; Olga Balafa
Journal:  Nat Rev Nephrol       Date:  2010-06-22       Impact factor: 28.314

5.  Infusion fluids contain harmful glucose degradation products.

Authors:  Anna Bryland; Marcus Broman; Martin Erixon; Bengt Klarin; Torbjörn Lindén; Hans Friberg; Anders Wieslander; Per Kjellstrand; Claudio Ronco; Ola Carlsson; Gabriela Godaly
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

Review 6.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

7.  Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study.

Authors:  Masaaki Nakayama; Masanobu Miyazaki; Kazuho Honda; Kenji Kasai; Tadashi Tomo; Hidetomo Nakamoto; Hideki Kawanishi
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

8.  Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.

Authors:  F Schneble; K E Bonzel; R Waldherr; S Bachmann; H Roth; K Schärer
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 9.  Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.

Authors:  Mufazzal Ahmad; Hemal Shah; Theodori Pliakogiannis; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-09-27       Impact factor: 2.266

10.  Peritoneal dialysis: from bench to bedside.

Authors:  Raymond T Krediet
Journal:  Clin Kidney J       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.